- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05249465
Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention
Optimizing Self-monitoring in a Digital Health Intervention for Weight Loss
This optimization trial will examine three tracking (or "self-monitoring") strategies for weight loss -- tracking dietary intake, steps, and/or body weight -- all delivered through digital health tools. The purpose of the study is to evaluate the combination of these strategies that maximizes 6-month weight loss in the context of a standalone digital health intervention for adults with overweight or obesity.
The investigators will recruit 176 total participants to the trial. Recruitment will occur through remote channels. Interested individuals will be directed to an online screening questionnaire; those who are eligible will then be invited to attend an initial remote session with study personnel to ensure interest and eligibility in the study. The weight loss intervention will last 6 months, and all participants will receive a "core" treatment consisting of goal setting, behavioral lessons, action plans, and tailored feedback - all of which will be delivered remotely. Depending on which group participants are assigned to in the study, some individuals will be asked to track their dietary intake, their steps, and/or their body weight via digital tools. All study tasks will occur remotely, thus, participants never need to come in-person for any intervention or assessment tasks.
The investigators will use the Multiphase Optimization Strategy (MOST) framework to identify the most effective combination of self-monitoring strategies. The factorial design will allow the research team to determine the unique and combined impact of each self-monitoring component on weight change. The primary outcome is weight change from baseline to 6 months. The research team will also assess self-monitoring engagement over 6 months and its association with weight change. To complement the main trial, the research team will also randomize half of participants to receive an interactive orientation video, in order to assess its impact on trial retention at 6 months. Overall, the information gathered from this trial will enable the construction of an optimized digital health intervention for weight loss that can be delivered remotely, which, if found to be effective, could have high potential for scalability.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- adults (ages 18+ years)
- body mass index (BMI) 25.0 to 45.0 kg/m^2
- smartphone ownership
- willingness to install a mobile app on their phone
- access to a personal email account
- English language proficiency
- interest in losing weight through behavioral strategies
Exclusion Criteria:
- concurrent enrollment in another weight management intervention
- loss of ≥10 lbs. in the past 6 months
- current use of a weight loss medication
- prior or planned bariatric surgery
- current or planned pregnancy in the trial period
- currently breastfeeding
- lives with someone else participating in the study
- hospitalization for a mental health condition in the past 12 months
- inability to engage in moderate forms of physical activity akin to brisk walking (assessed by the Physical Activity Readiness Questionnaire)
- if weight loss is contraindicated or might be impacted by a condition or medication (e.g., end stage renal disease, cancer, schizophrenia, dementia, steroids, anti-psychotics)
- if an individual would be better suited for a more intensive or different type of intervention based on a health condition (e.g., individuals with history of an eating disorder or cardiovascular event, uncontrolled hypertension, or uncontrolled diabetes mellitus)
- investigator discretion for safety reasons
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Condition 1
Core Only
|
All participants will receive a 6-month "core" behavioral obesity treatment consisting of goal setting, behavioral lessons, action plans, and tailored feedback - all of which will be delivered remotely.
|
|
Experimental: Condition 2
Core + Track Weight
|
All participants will receive a 6-month "core" behavioral obesity treatment consisting of goal setting, behavioral lessons, action plans, and tailored feedback - all of which will be delivered remotely.
Participants randomized to receive this component will be instructed to self-monitor their body weight daily via a wireless e-scale (e.g., the Fitbit Aria Scale).
|
|
Experimental: Condition 3
Core + Track Steps
|
All participants will receive a 6-month "core" behavioral obesity treatment consisting of goal setting, behavioral lessons, action plans, and tailored feedback - all of which will be delivered remotely.
Participants randomized to receive this component will be instructed to self-monitor their step count daily via a wrist-worn Fitbit activity monitor.
A daily step goal will be given that will adapt based on progress.
|
|
Experimental: Condition 4
Core + Track Diet
|
All participants will receive a 6-month "core" behavioral obesity treatment consisting of goal setting, behavioral lessons, action plans, and tailored feedback - all of which will be delivered remotely.
Participants randomized to receive this component will be instructed to self-monitor their dietary intake daily via the Fitbit mobile app.
Participants will receive a daily calorie goal.
|
|
Experimental: Condition 5
Core + Track Weight + Track Steps
|
All participants will receive a 6-month "core" behavioral obesity treatment consisting of goal setting, behavioral lessons, action plans, and tailored feedback - all of which will be delivered remotely.
Participants randomized to receive this component will be instructed to self-monitor their body weight daily via a wireless e-scale (e.g., the Fitbit Aria Scale).
Participants randomized to receive this component will be instructed to self-monitor their step count daily via a wrist-worn Fitbit activity monitor.
A daily step goal will be given that will adapt based on progress.
|
|
Experimental: Condition 6
Core + Track Weight + Track Diet
|
All participants will receive a 6-month "core" behavioral obesity treatment consisting of goal setting, behavioral lessons, action plans, and tailored feedback - all of which will be delivered remotely.
Participants randomized to receive this component will be instructed to self-monitor their body weight daily via a wireless e-scale (e.g., the Fitbit Aria Scale).
Participants randomized to receive this component will be instructed to self-monitor their dietary intake daily via the Fitbit mobile app.
Participants will receive a daily calorie goal.
|
|
Experimental: Condition 7
Core + Track Steps + Track Diet
|
All participants will receive a 6-month "core" behavioral obesity treatment consisting of goal setting, behavioral lessons, action plans, and tailored feedback - all of which will be delivered remotely.
Participants randomized to receive this component will be instructed to self-monitor their step count daily via a wrist-worn Fitbit activity monitor.
A daily step goal will be given that will adapt based on progress.
Participants randomized to receive this component will be instructed to self-monitor their dietary intake daily via the Fitbit mobile app.
Participants will receive a daily calorie goal.
|
|
Experimental: Condition 8
Core + Track Weight + Track Steps + Track Diet
|
All participants will receive a 6-month "core" behavioral obesity treatment consisting of goal setting, behavioral lessons, action plans, and tailored feedback - all of which will be delivered remotely.
Participants randomized to receive this component will be instructed to self-monitor their body weight daily via a wireless e-scale (e.g., the Fitbit Aria Scale).
Participants randomized to receive this component will be instructed to self-monitor their step count daily via a wrist-worn Fitbit activity monitor.
A daily step goal will be given that will adapt based on progress.
Participants randomized to receive this component will be instructed to self-monitor their dietary intake daily via the Fitbit mobile app.
Participants will receive a daily calorie goal.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body weight change from baseline to 6 months
Time Frame: baseline, 6 months
|
change in weight from baseline to 6-month followup (in kg); assessed objectively via e-scale
|
baseline, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinically significant weight loss
Time Frame: 6 months
|
proportion of participants achieving ≥5% weight loss from baseline
|
6 months
|
|
Physical activity change from baseline to 6 months
Time Frame: baseline, 6 months
|
change in physical activity from baseline to 6-month followup; assessed using Godin Leisure-Time Exercise Questionnaire
|
baseline, 6 months
|
|
Body weight from baseline to 1 month
Time Frame: baseline, 1 month
|
change in weight from baseline to 1-month followup (in kg); assessed objectively via e-scale
|
baseline, 1 month
|
|
Body weight from baseline to 3 months
Time Frame: baseline, 3 month
|
change in weight from baseline to 3-month followup (in kg); assessed objectively via e-scale
|
baseline, 3 month
|
|
BMI change from baseline to 6 months
Time Frame: baseline, 6 months
|
change in BMI from baseline to 6-month followup (in kg/m^2); computed from self-reported height and e-scale weight
|
baseline, 6 months
|
|
Caloric intake change from baseline to 6 months
Time Frame: baseline, 6 months
|
change in caloric intake from baseline to 6-month followup (in kcal); assessed using Automated 24-Hour (ASA-24) Dietary Assessment Tool (2 separate 24hr diet recalls at each time point: 1 week day, 1 weekend day)
|
baseline, 6 months
|
|
Engagement in self-monitoring dietary intake
Time Frame: 6 months of the intervention
|
average percent of days in the 6-month intervention of self-monitoring dietary intake; assessed objectively via digital health tools (mobile app)
|
6 months of the intervention
|
|
Engagement in self-monitoring weight
Time Frame: 6 months of the intervention
|
average percent of days in the 6-month intervention of self-monitoring weight; assessed objectively via digital health tools (e-scale)
|
6 months of the intervention
|
|
Engagement in self-monitoring steps
Time Frame: 6 months of the intervention
|
average percent of days in the 6-month intervention of self-monitoring steps; assessed objectively via digital health tools (activity monitor)
|
6 months of the intervention
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michele L Patel, PhD, Stanford University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 64716
- K23DK129805 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Core behavioral weight loss intervention
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Brown... and other collaboratorsRecruiting
-
Stanford UniversityNot yet recruitingObesity | Overweight | Weight Loss | Health Behavior | Lifestyle InterventionUnited States
-
University of PittsburghCompleted
-
University of ArkansasNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Maryland Cigarette Restitution FundCompletedKidney Cancer | Breast Cancer | Rectal Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Melanoma (Skin) | Gallbladder CancerUnited States
-
The University of Tennessee, KnoxvilleAmerican Heart AssociationCompleted
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Drexel UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI); Unrestricted research gift...Completed
-
University of ConnecticutNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University...Recruiting